Previous Close | 2.0800 |
Open | 2.0400 |
Bid | 1.9900 x 0 |
Ask | 2.0100 x 0 |
Day's Range | 1.9900 - 2.0500 |
52 Week Range | 0.8100 - 2.0800 |
Volume | |
Avg. Volume | 30,066 |
Market Cap | 31.395M |
Beta (5Y Monthly) | 0.95 |
PE Ratio (TTM) | 15.38 |
EPS (TTM) | 0.1300 |
Earnings Date | May 22, 2024 - May 27, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2023. Biorem's complete fiscal 2023 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
BIOREM Inc. (TSXV: BRM) ("BIOREM" or "The Company") today announced its results for the three and nine-month periods ended September 30, 2023. BIOREM's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2023. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).